Because of the similar expression and function of MGAT2 in human and mice, MGAT2-knockout mice have been very useful in helping in the discovery of small molecule MGAT2 inhibitors aimed at treating several lipid-related maladies, such as obesity, hypertriglyceridemia, and T2D. Here, MGAT2 is linked to obesity due to melanocortin 4 receptor deficiency.